Tamara Hampden 's Entries

1 blog
  • 12 Aug 2018
    Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, which includes the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to do so may be grounds for compensation. Our lawyers are working tough to get those hurt by the drug the compensation they're entitled to.Although bleeding is actually a common complication related with anticoagulants, it has been alleged that Xarelto is a lot more dangerous than conventional blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, inside the event of an emergency, individuals may be at threat for irreversible bleeding difficulties, such as life-threatening internal and gastrointestinal hemorrhaging.In case you or perhaps a loved one particular suffered a serious bleeding occasion soon after taking Xarelto, you may have legal recourse. For more info, speak to us right now to possess your case reviewed, cost-free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral expenses. http://www.cardiorete.it In addition, they may be in search of punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a secure anticoagulant option.Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.Visit this page for a lot more information on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
    75 Posted by Tamara Hampden
  • Our attorneys have filed a mass tort lawsuit on behalf of patients who took the blood thinner Xarelto (rivaroxaban) and suffered serious bleeding events. Pharmaceutical companies, which includes the makers of Xarelto, possess a duty to ensure that their drugs are reasonably safe for use - and failure to do so may be grounds for compensation. Our lawyers are working tough to get those hurt by the drug the compensation they're entitled to.Although bleeding is actually a common complication related with anticoagulants, it has been alleged that Xarelto is a lot more dangerous than conventional blood thinners since no antidote exists to reverse its blood-thinning effects. This means that, inside the event of an emergency, individuals may be at threat for irreversible bleeding difficulties, such as life-threatening internal and gastrointestinal hemorrhaging.In case you or perhaps a loved one particular suffered a serious bleeding occasion soon after taking Xarelto, you may have legal recourse. For more info, speak to us right now to possess your case reviewed, cost-free of charge.Compensation Possibilitiesxarelto-compensation-photoThe plaintiffs in these lawsuits are seeking compensation from Bayer and Janssen for past and future healthcare bills, lost wages, pain and suffering and, in cases of death, funeral expenses. http://www.cardiorete.it In addition, they may be in search of punitive damages, which are usually awarded to punish the defendant and deter other organizations from acting similarly.Why Are Lawsuits Getting Filed?Bayer and Johnson & Johnson’s Janssen Pharmaceuticals, Inc. are facing several Xarelto lawsuits alleging that the drug is unsafe and defective. The plaintiffs claim that, unlike traditional anticoagulants (e.g. warfarin, Coumadin) whose blood-thinning effects can be reversed using vitamin K, there is no antidote available for Xarelto. Simply because of this, the lawsuits claim, doctors have no effective indicates of stopping Xarelto users from bleeding in the occasion of an emergency. Plaintiffs in the lawsuits allege critical and fatal injuries, such as cerebral hemorrhaging and gastrointestinal bleeds, from use of the drug.In addition to these risks, lawsuits against Bayer and Johnson & Johnson’s Janssen Pharmaceuticals are alleging:The manufacturers of Xarelto marketed the drug as a superior inside the field of anticoagulants despite studies finding higher rates of gastrointestinal (GI tract) bleeding and transfusions in Xarelto users than users of certain competitors.The makers of the drug continue to market Xarelto as a secure anticoagulant option.Doctors and healthcare staff were not properly made aware of methods to stabilize and treat a Xarelto user within the occasion of a bleeding complication.Users of Xarelto were not adequately warned of the health risks of suffering a fatal bleeding event.Xarelto is linked to severe bleeding complications, excessive blood loss, intracranial hemorrhaging, eye bleeding (vitreous hemorrhage), stomach bleeding, gastrointestinal bleeding, wound infections from inhibited clotting, and lack of effectiveness in preventing hazardous clotting.Visit this page for a lot more information on the alleged health risks of Xarelto.Multidistrict Litigation Trial Dates SetThe attorneys within the Complex Litigation Group have filed lawsuits on behalf of injured clients. The claims will proceed through multidistrict litigation (MDL), which currently entails four trials, scheduled for Fall 2016, in which random groups of plaintiffs will be chosen to represent the group.
    Aug 12, 2018 75